Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using Latent Variables and Directly Observed Treatment to Improve the Diagnosis and Management of Depression Among Hemodialysis Patients

NCT03390933 is registered in ClinicalTrials.gov with MetroHealth Medical Center as lead sponsor.

NCT NCT03390933
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03390933 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using Latent Variables and Directly Observed Treatment to Improve the Diagnosis and Management of Depression Among Hemodialysis Patients
Lead sponsor
MetroHealth Medical Center
Phase
Phase 4
Overall status
Completed
Start date
March 1, 2018
Completion date
February 28, 2023
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, hemodialysis-induced symptom